id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8904 R30087 |
Aydin (Lamotrigine), 2020 | Preeclampsia/ eclampsia | throughout pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | 3.31 [0.06;183.69] C | 0/7 0/22 | 0 | 7 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8963 R30352 |
Cohen (Lamotrigine) (Mixed indications), 2019 | Preeclampsia | early pregnancy | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes | 1.07 [0.88;1.29] | 129/2,682 53,634/1,440,631 | 53,763 | 2,682 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8958 R30339 |
Borthen (Lamotrigine) (Controls unexposed, disease free), 2011 | Pre-eclampsia | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, disease free excluded | Adjustment: No Matched |
4.40 [1.50;13.00] excluded (control group) |
6/30 11/205 | 17 | 30 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8960 R30347 |
Borthen (Lamotrigine) (Controls unexposed, sick), 2011 | Pre-eclampsia | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 1.77 [0.59;5.30] C | 6/30 11/89 | 17 | 30 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.09 [0.90;1.31] | 53,780 | 2,719 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Lamotrigine; 2: Lamotrigine) (Mixed indications; 3: Lamotrigine) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 8958